ADD (Metabolic Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameADD (Metabolic Pharmaceuticals)

Drug Alias Nametype 2 diabetes therapy (Metabolic)Advanced Diabetes Drug (Metabolic)Anti-Diabetic Drug (Metabolic Pharmaceuticals)ADD-9903ADD-9922 +[6]

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionInsulin sensitizers

TargetsUpdating

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPolynovo

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPolynovo

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A